Johnson & Johnson as of Dec. 31, 2025
Portfolio Holdings for Johnson & Johnson
Johnson & Johnson holds 17 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Protagonist Therapeutics (PTGX) | 38.6 | $214M | 2.4M | 87.34 | |
| Nanobiotix Sponsored Ads (NBTX) | 23.4 | $130M | 5.6M | 23.12 | |
| Rapport Therapeutics (RAPP) | 9.8 | $54M | 1.8M | 30.34 | |
| Meiragtx Holdings (MGTX) | 9.5 | $53M | 6.6M | 7.95 | |
| CVRX (CVRX) | 5.2 | $29M | 4.0M | 7.10 | |
| Contineum Therapeutics Cl A (CTNM) | 4.1 | $23M | 2.0M | 11.43 | |
| Legend Biotech Corporation Sponsored Ads (LEGN) | 3.2 | $18M | 815k | 21.74 | |
| Xencor (XNCR) | 2.1 | $12M | 748k | 15.31 | |
| Procept Biorobotics Corp (PRCT) | 2.0 | $11M | 358k | 31.46 | |
| Fate Therapeutics (FATE) | 0.6 | $3.3M | 3.4M | 0.98 | |
| Neumora Therapeutics (NMRA) | 0.6 | $3.3M | 1.8M | 1.79 | |
| Rallybio Corp (RLYB) | 0.4 | $2.5M | 3.6M | 0.69 | |
| Lyell Immunopharma Com New (LYEL) | 0.2 | $1.3M | 41k | 30.78 | |
| Vor Biopharma Com New (VOR) | 0.1 | $703k | 54k | 13.08 | |
| Nano-X Imaging Ord Shs (NNOX) | 0.1 | $445k | 159k | 2.80 | |
| D Fluidigm Corp Del (LAB) | 0.1 | $399k | 312k | 1.28 | |
| Adicet Bio Com New (ACET) | 0.0 | $192k | 23k | 8.42 |
